Insider Transactions in Q4 2021 at Kezar Life Sciences, Inc. (KZR)
Insider Transaction List (Q4 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 14
2021
|
John Franklin Fowler CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,700
+2.06%
|
$0
$0.9 P/Share
|